Volume 126, Issue 1, Pages (January 2004)

Slides:

Advertisements

Similar presentations

Genetic testing for high-risk colon cancer patients1 William M. Grady Gastroenterology Volume 124, Issue 6, Pages (May 2003) DOI: /S (03)

Advertisements

Overview and pathogenesis of celiac disease Martin F. Kagnoff Gastroenterology Volume 128, Issue 4, Pages S10-S18 (April 2005) DOI: /j.gastro

Crohn's disease Prof Daniel C Baumgart, MD, Prof William J Sandborn, MD The Lancet Volume 380, Issue 9853, Pages (November 2012) DOI: /S (12)

My Treatment Approach to Hairy Cell Leukemia Rahul R. Naik, MD, Alan Saven, MD Mayo Clinic Proceedings Volume 87, Issue 1, Pages (January 2012) DOI:

Volume 117, Issue 2, Pages (August 1999)

Volume 137, Issue 4, Pages (October 2009)

Thierry Delaunoit, Paul J. Limburg, Richard M. Goldberg, James F

Volume 126, Issue 7, Pages (June 2004)

The Role of Psychosocial Care in Adapting to Health Care Reform

Johnson L. Thistle, George F. Longstreth, Yvonne Romero, Amindra S

Volume 135, Issue 4, Pages (October 2008)

Evaluation and Management of End-Stage Liver Disease in Children

Covering the Cover Gastroenterology

Rok Seon Choung, G. Richard Locke, Enrique Rey, Cathy D

Volume 126, Pages S164-S168 (January 2004)

Validation of the Ulcerative Colitis Colonoscopic Index of Severity and Its Correlation With Disease Activity Measures Sunil Samuel, David H. Bruining,

Volume 126, Issue 7, Pages (June 2004)

Volume 133, Issue 1, Pages (July 2007)

Ira J. Fox, Stephen C. Strom Gastroenterology

Volume 130, Issue 4, Pages (April 2006)

Laurent Peyrin-Biroulet, Julián Panés, William J

Volume 133, Issue 3, Pages e1 (September 2007)

Volume 135, Issue 5, Pages (November 2008)

Adil E. Bharucha, Alan R. Zinsmeister, G

Computed Tomography Enterography Detects Intestinal Wall Changes and Effects of Treatment in Patients With Crohn's Disease David H. Bruining, Edward.

A Historical Perspective on Clinical Advances in Pancreatic Diseases

Gary R. Lichtenstein, Brian G. Feagan, Russell D. Cohen, Bruce A

Structure of grepafloxacin relative to activity and safety profile

Volume 155, Issue 1, Pages (July 2018)

Volume 123, Issue 2, Pages (August 2002)

AGA Clinical Practice Update on Functional Gastrointestinal Symptoms in Patients With Inflammatory Bowel Disease: Expert Review Jean-Frederic Colombel,

Retrospective study of CMV retinitis in patients with AIDS

A Test-based Strategy Is More Cost Effective Than Empiric Dose Escalation for Patients With Crohn's Disease Who Lose Responsiveness to Infliximab Fernando.

Volume 117, Issue 2, Pages (August 1999)

Volume 137, Issue 4, Pages (October 2009)

Volume 146, Issue 4, Pages e2 (April 2014)

Increased Prevalence and Mortality in Undiagnosed Celiac Disease

Volume 132, Issue 1, Pages (January 2007)

Covering the Cover Gastroenterology

David H. Bruining, William J. Sandborn

Volume 135, Issue 5, Pages (November 2008)

Volume 133, Issue 2, Pages (August 2007)

Clinically important body weight gain following total hip arthroplasty: a cohort study with 5-year follow-up D.L. Riddle, J.A. Singh, W.S. Harmsen, C.D.

Raina Shivashankar, Sahil Khanna, Patricia P. Kammer, W

Antoine Debourdeau, Anne Bozon, Romain Altwegg Gastroenterology

Volume 121, Issue 5, Pages (November 2001)

Volume 150, Issue 7, Pages (June 2016)

Multiple Unusual Ulcerated Skin Lesions in a Crohn's Disease Patient

Initiating Azathioprine for Crohn's Disease

A Population-based Study of Incidence, Risk Factors, Clinical Spectrum, and Outcomes of Ischemic Colitis Siddhant Yadav, Maneesh Dave, Jithinraj Edakkanambeth.

Safety of Long-term Treatment With Certolizumab Pegol in Patients With Crohn's Disease, Based on a Pooled Analysis of Data From Clinical Trials Edward.

Covering the Cover Gastroenterology

Volume 126, Issue 2, Pages (February 2004)

Reinduction With Certolizumab Pegol in Patients With Relapsed Crohn's Disease: Results From the PRECiSE 4 Study William J. Sandborn, Stefan Schreiber,

Richard J. Saad, William D. Chey Gastroenterology

Volume 151, Issue 4, Pages (October 2016)

Nicolas Williet, William J. Sandborn, Laurent Peyrin–Biroulet

Volume 126, Issue 1, Pages (January 2004)

Relationships Between Disease Activity and Serum and Fecal Biomarkers in Patients With Crohn's Disease Jennifer Jones, Edward V. Loftus, Remo Panaccione,

Walter Reinisch, Jean-Frederic Colombel, William J

Volume 128, Issue 7, Pages (June 2005)

Michelle Maria Pietzak Gastroenterology

Volume 139, Issue 6, Pages e1 (December 2010)

Endoscopic Assessment and Treating to Target Increase the Likelihood of Mucosal Healing in Patients With Crohn’s Disease Guillaume Bouguen, Barrett G.

Successful treatment of cap polyposis with infliximab

Medical Therapy for Refractory Pediatric Crohn’s Disease

Volume 129, Issue 1, Pages (July 2005)

Thierry Delaunoit, Paul J. Limburg, Richard M. Goldberg, James F

The Role of Psychosocial Care in Adapting to Health Care Reform

Combination Therapy With Infliximab and Azathioprine Improves Infliximab Pharmacokinetic Features and Efficacy: A Post Hoc Analysis Jean-Frédéric Colombel,

Presentation transcript:

Volume 126, Issue 1, Pages 19-31 (January 2004) The safety profile of infliximab in patients with Crohn’s disease: The Mayo Clinic experience in 500 patients Jean-Frederic Colombel, Edward V. Loftus, William J. Tremaine, Laurence J. Egan, W.Scott Harmsen, Cathy D. Schleck, Alan R. Zinsmeister, William J. Sandborn Gastroenterology Volume 126, Issue 1, Pages 19-31 (January 2004) DOI: 10.1053/j.gastro.2003.10.047

Figure 1 The cumulative probability of an infectious complication relative to the number of infliximab infusions in 500 patients. Gastroenterology 2004 126, 19-31DOI: (10.1053/j.gastro.2003.10.047)